Key Highlights

  • Tradr 2X Short CBRS Daily ETF (CBOE:CBRZ) rose 14.13% to USD 23.99 on October 22, 2026, from about USD 21.02, implying Cerebras fell about 7.1%, simple arithmetic on the published change and the quote.
  • Cerebras reported second-quarter GAAP Revenue of USD 180.1 million, up 74%, and core revenue of USD 209.9 million, up 103%, and raised its 2026 core revenue outlook to USD 880 million to USD 890 million.
  • Remaining performance obligations were USD 25.4 billion, mostly tied to OpenAI's agreement worth more than USD 20 billion for 750 megawatts, but GAAP gross Margin was only 14%.
  • The fund launched on May 28, 2026, charges 1.49% and held about USD 2.8 million in assets, so it is thin and spreads can be wide.

What Moved the Fund

The fund rose 14.13% in the October 22, 2026 session, implying Cerebras fell about 7.1%. No Cerebras-specific release was found for the day. The drop came in a broad AI and semiconductor selloff. Lam Research (NASDAQ:LRCX) posted record revenue of USD 8.22 billion on October 21, 2026, then fell about 9% on October 22 after guiding December-quarter revenue to USD 8.6 billion, plus or minus USD 400 million, and citing Supply constraints. Cerebras, which went public in May 2026, is a high-multiple AI chip stock tied to a few customers, so it tends to move more than larger peers when AI spending worries return, and the fund's price has risen sharply from USD 14.32 on October 12.

Cerebras Fundamentals

Cerebras Systems (NASDAQ:CBRS) reported second-quarter results on August 12, 2026. GAAP revenue was USD 180.1 million and core revenue was USD 209.9 million, with cloud revenue up 281%. Guidance for the third quarter is core revenue of USD 214 million to USD 216 million at a 38% to 40% core gross margin, and full-year core margin of 41% to 43%. The net loss was USD 450.5 million, of which USD 386.6 million related to stock-based compensation, according to reports. In the first quarter, G42 and MBZUAI accounted for 74% of revenue and OpenAI for 9%, so concentration is high. Shares fell about 14% after hours on the August report.

Mechanics and Risks

CBRZ, issued by Tradr, trades on Cboe BZX and targets minus 2x of Cerebras's daily return using swaps, resetting daily. If Cerebras rose 12% then fell 12%, the stock would end down 1.44% while the fund would end down 5.76%, simple arithmetic. With only about USD 2.8 million in Assets the fund can have wide spreads and closure risk. A one-day rise above 50% would erase it, and a lockup expiry or new OpenAI capacity news could trigger a rebound. Swap financing adds to the cost. Tracking can drift on days of extreme moves, and the fund is concentrated in one stock. The fund resets after the close each day.

Where Things Stand

Tradr 2X Short CBRS Daily ETF (CBOE:CBRZ) gained because Cerebras fell about 7.1% in an AI and semiconductor selloff, and the fund pays twice the inverse. Cerebras has a large Backlog and rising revenue, but margins are thin, losses are large and customer concentration is high. The next markers are third-quarter results, with date unconfirmed, and any news on OpenAI deployment timelines that could move the shares sharply. Customer concentration remains the key variable.